It is possible that spider silk could also be used in future for other neurological diseases
where cell transplantation plays a role.
Not exact matches
Previously, Dr. Nikolic was an Assistant Professor in Medicine at Harvard Medical School
where he led an advanced immunology laboratory for tolerance induction and stem -
cell transplantation at Massachusetts General Hospital / Harvard Medical School.
Dr. Cooper joined MDACC in 2006 as section chief of
cell therapy at the Children's Cancer Hospital,
where he cared for children undergoing bone marrow
transplantation and led scientific efforts to develop new treatment approaches that pair genetic engineering with immunotherapies.
The only documented long - term complete remissions reported in multiple myeloma patients have occurred with allogeneic bone marrow
transplantation,
where a donor's blood stem
cells (graft) are transplanted into the patient (host) with multiple myeloma.
He moved to the Scripps Clinic and Research Foundation in La Jolla, USA from 1975 to 1979,
where he studied T
cell maturation and development of the T
cell repertoire, dependent on the
transplantation antigen expression in the thymus.
With a personal desire to make a truly positive impact on people's lives, Dr. Dipnarine Maharaj chose to study Hematology / Oncology and Stem
Cell Transplantation because that is
where he felt he could make a real difference in the quality and advancement of health care.
With a personal desire to make a truly positive impact on people's lives, Dr. Dipnarine Maharaj chose to study Internal Medicine, Hematology / Oncology and Stem
Cell Transplantation because that is
where he felt he could make a real difference in the quality and advancement of health care.
It is conceivable the techniques being developed might have some application in future stem
cell therapies in humans
where a cloning process was used to generate particular tissues for
transplantation.
This includes
transplantation into parts of the body
where the replacement
cells are less likely to be attacked by the immune system or placement of the
cells into protective capsules.
1994 saw her as Head of the Department of
Transplantation Immunology at the CLB, in Amsterdam, and in 1999 she became Head of the department of the Immunology of the Laboratory of Vaccine Research of the National Institute of Public Health and Environmental Protection (RIVM), in Bilthoven,
where her research activities focused on defining immunological correlates of protection on the T and B
cell level after natural infection and vaccination.
In 1993, he joined the Divisions of Experimental Hematology and Bone Marrow
Transplantation at St. Jude Children's Research Hospital in Memphis,
where he was appointed director of the
cell and gene therapy laboratories, as well as chair of the institutional review board.